AMETEK, Inc. (NYSE:AME) was the recipient of unusually large options trading activity on Monday. Traders acquired 1,309 call options on the company. This is an increase of approximately 1,883% compared to the average volume of 66 call options.
In other news, insider Thomas C. Marecic sold 13,990 shares of AMETEK stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $95.02, for a total transaction of $1,329,329.80. Following the sale, the insider now directly owns 36,014 shares of the company’s stock, valued at $3,422,050.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO William Joseph Burke sold 12,510 shares of AMETEK stock in a transaction dated Tuesday, November 19th. The shares were sold at an average price of $98.51, for a total value of $1,232,360.10. Following the sale, the chief financial officer now directly owns 81,526 shares in the company, valued at $8,031,126.26. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 49,070 shares of company stock worth $4,745,902. Insiders own 0.80% of the company’s stock.
Several institutional investors and hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in AMETEK by 1.7% during the second quarter. Vanguard Group Inc. now owns 24,128,928 shares of the technology company’s stock valued at $2,191,872,000 after acquiring an additional 396,995 shares during the last quarter. BlackRock Inc. lifted its stake in shares of AMETEK by 1.3% in the 2nd quarter. BlackRock Inc. now owns 15,418,675 shares of the technology company’s stock valued at $1,400,633,000 after purchasing an additional 204,374 shares during the period. Massachusetts Financial Services Co. MA boosted its position in shares of AMETEK by 1.2% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 6,610,756 shares of the technology company’s stock valued at $607,001,000 after purchasing an additional 76,480 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of AMETEK by 18.1% during the 2nd quarter. JPMorgan Chase & Co. now owns 4,896,915 shares of the technology company’s stock valued at $432,202,000 after purchasing an additional 749,865 shares in the last quarter. Finally, Mawer Investment Management Ltd. grew its stake in AMETEK by 8.4% during the second quarter. Mawer Investment Management Ltd. now owns 3,234,280 shares of the technology company’s stock worth $293,710,000 after purchasing an additional 251,218 shares during the period. Institutional investors own 86.26% of the company’s stock.
AMETEK stock opened at $97.54 on Tuesday. The stock’s 50 day moving average is $94.33 and its 200 day moving average is $89.17. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.05 and a quick ratio of 1.48. The firm has a market cap of $22.63 billion, a P/E ratio of 29.65, a P/E/G ratio of 2.19 and a beta of 1.23. AMETEK has a one year low of $63.14 and a one year high of $99.74.
AMETEK (NYSE:AME) last released its earnings results on Thursday, October 31st. The technology company reported $1.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.01 by $0.05. AMETEK had a net margin of 16.63% and a return on equity of 20.04%. The business had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.28 billion. During the same quarter in the prior year, the firm posted $0.91 EPS. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. Equities analysts anticipate that AMETEK will post 4.14 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be paid a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.57%. The ex-dividend date is Thursday, December 5th. AMETEK’s dividend payout ratio is currently 17.02%.
Several research analysts have recently issued reports on the company. Wolfe Research set a $100.00 price objective on AMETEK and gave the company a “buy” rating in a research note on Friday, November 1st. Morgan Stanley set a $102.00 target price on shares of AMETEK and gave the stock a “buy” rating in a report on Friday, November 1st. ValuEngine raised shares of AMETEK from a “sell” rating to a “hold” rating in a report on Friday, November 1st. KeyCorp upped their price target on shares of AMETEK from $100.00 to $110.00 and gave the company an “overweight” rating in a research report on Tuesday, November 19th. Finally, Rosenblatt Securities began coverage on shares of AMETEK in a research note on Thursday, November 7th. They set a “buy” rating and a $115.00 price target for the company. Two analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. AMETEK presently has a consensus rating of “Buy” and a consensus price target of $100.29.
AMETEK Company Profile
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. The company's Electronic Instruments segment offers advanced instruments for the process, aerospace, power, and industrial markets; process control instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.
Recommended Story: Does a trade war provide a risk to the global economy?
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.